Case Report
BibTex RIS Cite

Autoimmune Hemolytic Anemia Developing Secondary to Epstein-Barr Virus Infection: A case report

Year 2020, Volume: 5 Issue: 1, 199 - 202, 31.03.2020
https://doi.org/10.26453/otjhs.637602

Abstract

Infectious mononucleosis (EM) is a disease characterized by irradiation of the Epstein-Barr virus (EBV). The clinical manifestation is characterized by tonsillopharyngitis, lym-phadenopathy and atypical lymphocytosis. We describe a young patient developing hemolytic anemia during follow-up in our clinic due to tonsillopharyngitis secondary to EBV and general condition disorder.

References

  • 1. Johannsen EC, Schooley RT, Kaye KM. Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 6th ed. Vol 2. Philadelphia: Elsevier Churchill Livingstone, 2005:1801-20.
  • 2. Arman D. Epstein-Barr virüs. Topçu Wilke A, Söyletir G, Doğanay M (editörler). İnfeksiyon Hastalıkları ve Mikrobiyolojisi. 1. Baskı. İstanbul: Nobel Tıp Kitabevleri, 2002:1197-201.
  • 3. Lennon P, Saunders J, Fenton JE. A longer stay for the kissing disease: epidemiology of bacterial tonsillitis and infectious mononucleosis over a 20- year period. J Laryngol Otol. 2013;7:1-5.
  • 4. Cohen JI. Treatment of infectious mononucleosis: When and how? The Herpes Monitor. 2003;3:1-5.
  • 5. Straus SE, Cohen JI, Tosato G, Meier J. Epstein-Barr virus infections: Biology, pathogenesis and management. Ann Intern Med. 1993;118:45-58.
  • 6. Tynell E, Aurelius E, Brandell A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: A multicenter, double-bind, plasebocontrolled study. J Infect Dis. 1996;174:324-31.
  • 7. H.B. Jenson. Acute complications of Epstein–Barr virus infectious mononucleosis. Curr Opin Pediatr. 12 (2000), pp. 263-268.
  • 8. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014:1457-1554.
  • 9. E. C. Besa, Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. The American Journal of Medicine. 1988:691-8.
  • 10. Vouloumanou E.K, Rafailidis P.I, Falagas M.E. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol. 2012;19(1):14-20.

Epstein-Barr Virus İnfeksiyonuna Sekonder Olarak Gelişen Otoimmun Hemolitik Anemi: Bir Vaka Raporu

Year 2020, Volume: 5 Issue: 1, 199 - 202, 31.03.2020
https://doi.org/10.26453/otjhs.637602

Abstract

Enfeksiyöz mononükleoz (EM), Epstein-Barr virüsünün (EBV) yayılması ile karakterize bir hastalıktır. Klinik bul-gular tonsillofarenjit, lenfadenopati ve atipik lenfositoz ile karakterizedir. EBV'ye sekonder tonsillofarenjit ve genel durum bozukluğu nedeniyle kliniğimizde takip sırasında hemolitik anemi gelişen genç bir hastayı tanımladık.

References

  • 1. Johannsen EC, Schooley RT, Kaye KM. Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 6th ed. Vol 2. Philadelphia: Elsevier Churchill Livingstone, 2005:1801-20.
  • 2. Arman D. Epstein-Barr virüs. Topçu Wilke A, Söyletir G, Doğanay M (editörler). İnfeksiyon Hastalıkları ve Mikrobiyolojisi. 1. Baskı. İstanbul: Nobel Tıp Kitabevleri, 2002:1197-201.
  • 3. Lennon P, Saunders J, Fenton JE. A longer stay for the kissing disease: epidemiology of bacterial tonsillitis and infectious mononucleosis over a 20- year period. J Laryngol Otol. 2013;7:1-5.
  • 4. Cohen JI. Treatment of infectious mononucleosis: When and how? The Herpes Monitor. 2003;3:1-5.
  • 5. Straus SE, Cohen JI, Tosato G, Meier J. Epstein-Barr virus infections: Biology, pathogenesis and management. Ann Intern Med. 1993;118:45-58.
  • 6. Tynell E, Aurelius E, Brandell A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: A multicenter, double-bind, plasebocontrolled study. J Infect Dis. 1996;174:324-31.
  • 7. H.B. Jenson. Acute complications of Epstein–Barr virus infectious mononucleosis. Curr Opin Pediatr. 12 (2000), pp. 263-268.
  • 8. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014:1457-1554.
  • 9. E. C. Besa, Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. The American Journal of Medicine. 1988:691-8.
  • 10. Vouloumanou E.K, Rafailidis P.I, Falagas M.E. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol. 2012;19(1):14-20.
There are 10 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Case report
Authors

Nevin İnce 0000-0002-0129-4536

Elif Çelik This is me 0000-0003-2871-8156

Birgül Öneç 0000-0003-2824-1044

Hilal Şöhret Uyanık This is me 0000-0002-7410-633X

Publication Date March 31, 2020
Submission Date October 24, 2019
Acceptance Date December 20, 2019
Published in Issue Year 2020 Volume: 5 Issue: 1

Cite

AMA İnce N, Çelik E, Öneç B, Uyanık HŞ. Autoimmune Hemolytic Anemia Developing Secondary to Epstein-Barr Virus Infection: A case report. OTJHS. March 2020;5(1):199-202. doi:10.26453/otjhs.637602

Creative Commons License

Online Türk Sağlık Bilimleri Dergisi [Online Turkish Journal of Health Sciences (OTJHS)] is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access journal distributed under the terms of the Creative Commons Attribution License (CC BY-NC 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Click here to get help about article submission processes and "Copyright Transfer Form".